How does immunohistochemistry support personalized medicine?
Immunohistochemical technology provides a key basis for individualized treatment plans by precisely locating tumor-specific protein markers. According to an analysis of 12,500 cancer patients in the 2023 Journal of the American Medical Association Oncology, among breast cancer patients who underwent HER2/ER/PR detection using immunohistochemistry, the accuracy rate of identifying the applicable population for targeted drugs …
How does immunohistochemistry support personalized medicine? Read More »